Selective targeting of pro-inflammatory Th1 cells by microRNA-148a-specific antagomirs in vivo
Under a Creative Commons license
open access
Keywords
Inflammatory bowel disease
Pro-inflammatory Th1 cells
Chronic inflammation
miRNA-148a
Oligonucleotide therapy
Pre-clinical study
Antagomirs
Cited by (0)
- 1
Present address: Maurice Müller Laboratories (DKF), Universitätsklinik für Viszerale Chirurgie & Medizin Inselspital, University of Bern, Bern, Switzerland.
- 2
Present address: Max Planck Institute for Evolutionary Biology, Evolutionary Genomics Group, Plön, Germany.
- 3
A.R. and M.F.M. equal contribution.
© 2017 The Authors. Published by Elsevier Ltd.